VDA Pharma, Inc. — Form D

VDA Pharma, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2015-09-24. The offering totals $80K, of which $55K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2015-09-24
• Form: D
• Accession: 0001654001-15-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $80K
• Amount sold: $55K
• Remaining: $25K
• Minimum investment: $5K
• Investors: 4
• Date of first sale: 2015-08-23
• Security types: debt
• Revenue range: No Revenues
• SEC file number: 021-248202

Issuer

• Name: VDA Pharma, Inc.
• CIK: 0001654001
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2011
• Address: 500 UNION STREET, SEATTLE, WA, 98101
• Phone: 206-682-1181

Officers, directors & promoters (1)

More

• CIK 1654001 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search